Market Report Source

Overview

Introduction
Urinary incontinence and overactive bladder disorders are estimated to affect more than 10% of the female population. However, presentation, diagnosis and treatments rates are poor. In the US, the employment of Continence Nurses provides an ideal opportunity to ensure that patients are able to gain access to expert advice and treatment.

Scope
Assessment of the responsibilities of the US Continence Nurse including their role in the referral pathway, diagnosis and prescribing of drug therapy
Evaluation of reasons influencing patient presentation including educational and marketing campaigns
Analysis of treatment methods employed, influences on treatment choice and perception of current drug therapies
Identification of unmet needs and potential drivers of change

Highlights
Continence Nurses in the US play a varied role in the management of urinary incontinence and overactive bladder patients, with over two thirds recommending or prescribing pharmacological therapies. Pharmaceutical companies promoting pharmacological therapies in the US should consider Continence Nurses as key targets.

For more than 50% of patients presenting to Continence Nurses, this is the first healthcare professional that the patient will have spoken to about their condition; frequently identified as a direct result of presenting for another condition. Therefore, Continence Nurses are vital to the diagnosis and referral of this subgroup of patients.

Continence Nurses are likely to have more time than other physicians to discuss the nature of symptoms and side effects with patients. By supporting Continence Nurses, pharmaceutical companies could improve patients’ knowledge of the condition and its treatment, thereby improving treatment retention and switching rates.

Reasons to Purchase
Understand the role of Continence Nurses in the treatment of urinary incontinence and overactive bladder for strategic product planning and targeting
Evaluate methods for improving presentation rates and thereby utilization of treatments for urinary incontinence and overactive bladder disorders
Identify concerns of Continence Nurses and patients regarding current treatment and unmet needs”

Table of Contents

TABLE OF CONTENTS

OVERVIEW

This product has been designed for delivery in a slide pack format (PowerPoint).

Please select the slide pack option from the download menu at the side of the page

Introduction

Scope of this report

Research and analysis highlights

Key reasons to read this report

APPENDIX A

Research methodology

Continence nurse questionnaire

Screening Information

Overview of the study

Section One epidemiology

Section Two Presentation and help seeking behavior

Section Three Diagnosis and management

Referral pattern

Section Four Treatment

Non-pharmacological treatment

Pharmacological treatment

Section Five General

Section A: Drug influences

Section B: The general treatment of urinary incontinence and overactive bladder

Contributing experts

US

Japan

Europe

APPENDIX B

About Datamonitor

About Datamonitor Healthcare

About the CNS analysis team

Disclaimer